絞り込み

16406

広告

「elotuzumab」の検索結果

163件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient.

The effect of novel therapies in high-molecular-risk multiple myeloma.

Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update.

Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.

[Multiple myeloma : What has been confirmed in therapy?]

A review discussing elotuzumab and its use in the second-line plus treatment of multiple myeloma.

SLAMF7-CAR T-cells eliminate myeloma and confer selective fratricide of SLAMF7(+) normal lymphocytes.

Therapeutic approach for relapsed/refractory multiple myeloma: the logic and practice.

Meta-analysis of the efficacy of treatments for newly diagnosed and relapsed/refractory multiple myeloma with del(17p).

The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms.

Treatment algorithms for multiple myeloma in Japan.

Combination therapy with monoclonal antibodies for treatment of newly diagnosed multiple myeloma.

CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.

Adoptive Cell Therapy in Multiple Myeloma.

The Clinical Pharmacology of Elotuzumab.

Immunotherapy in Multiple Myeloma.

How I treat: New agents in myeloma.

Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab.

Monoclonal Antibodies in Multiple Myeloma: A New Wave of the Future.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
Sort by
※並べ替えは表示に時間がかかります